ctDNA Sequencing Predicts Likelihood of Immunotherapy Response – Cancer Therapy Advisor
Cancer Therapy Advisor |
ctDNA Sequencing Predicts Likelihood of Immunotherapy Response
Cancer Therapy Advisor Mutations in circulating tumor DNA (ctDNA) may indicate which patients are likely to respond to checkpoint inhibition, according to research published in Clinical Cancer Research.1. While immunotherapy with PD-1, PD-L1, and CTLA-4 inhibition is … |
